Prof. Dr. BİLGE VOLKAN SALANCI

Yayın Ağı

Makaleler 43

1. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ TURAN B., Yalcin-cakmakli G., ERGÜN E., Dasgin H., Karli Oguz K., ELİBOL B., et al.

ANNALS OF NUCLEAR MEDICINE , 2025 (SCI-Expanded, Scopus)

2. Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres

Soydas-Turan B., Bozkurt M. F., Eldem G., PEYNİRCİOĞLU B., UĞUR Ö., VOLKAN SALANCI B.

ANNALS OF NUCLEAR MEDICINE , sa.4, ss.373-379, 2025 (SCI-Expanded, Scopus)

3. Current approach to pediatric differentiated thyroid cancer

Ozgen Kiratli P., VOLKAN SALANCI B.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. , cilt.68, sa.1, ss.32-39, 2024 (SCI-Expanded, Scopus)

4. An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease

Ozolmez N., SİLİNDİR GÜNAY M., VOLKAN SALANCI B.

APPLIED RADIATION AND ISOTOPES , cilt.203, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Comparison of Dopaminergic and Metabolic Imaging in Monogenic and Idiopathic Parkinson Disease

Turan B. S., Volkan-Salanci B., Ergun E. L., UĞUR Ö., Yalcin-Cakmakli G., Oguz K. K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

6. How Current Risk Stratification Changed Our Practice in Pediatric Thyroid Cancer Patients? An Institutional Experience

Isik Z., Volkan-Salanci B., Kiratli P.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

7. Determination of Normal Gastric Emptying Values in Pediatric Age Groups

Isik Z., Volkan-Salanci B., Kiratli P.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

8. Can Semiquantitative 18FDG PET/CT Parameters Predict Outcome in Paediatric Patients with Ewing Sarcoma?

Turan B. S., Volkan-Salanci B., Aydin G. B., Emirsuleymanoglu E., Kiratli P. O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

9. Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting

VOLKAN SALANCI B., Erbas B.

SEMINARS IN NUCLEAR MEDICINE , cilt.52, sa.4, ss.445-452, 2022 (SCI-Expanded, Scopus)

10. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma

MAVİ M. E., Turan B. S., VOLKAN SALANCI B., BOZKURT M. F.

CLINICAL NUCLEAR MEDICINE , cilt.47, sa.5, 2022 (SCI-Expanded, Scopus)

11. Lateralized Periodic Discharges in a Patient With Dural Arteriovenous Fistula: SPECT and DWI Studies Suggest They are Ictal

DERİCİOĞLU N., VOLKAN SALANCI B., GÖÇMEN R., ARAT A.

CLINICAL EEG AND NEUROSCIENCE , cilt.53, sa.2, ss.138-142, 2022 (SCI-Expanded, Scopus)

12. LONG TERM FOLLOW UP IN RENAL SCARRING OF URINARY TRACT INFECTION: ALBUMINURIA, DIASTOLIC BLOOD PRESSURE

BALTU D., VOLKAN SALANCI B., GÜLHAN B., TAŞTEMEL ÖZTÜRK T., KURT ŞÜKÜR E. D., ÖZALTIN F., et al.

PEDIATRIC NEPHROLOGY , cilt.36, sa.10, ss.3434, 2021 (SCI-Expanded, Scopus)

13. Imaging in Renal Transplants: An Update

VOLKAN SALANCI B., Erbas B.

SEMINARS IN NUCLEAR MEDICINE , cilt.51, sa.4, ss.364-379, 2021 (SCI-Expanded, Scopus)

14. Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients

Bozkurt M., Eldem G., Bozbulut U. B., BOZKURT M. F., KILIÇKAP S., PEYNİRCİOĞLU B., et al.

RADIOLOGIA MEDICA , cilt.126, sa.2, ss.323-333, 2021 (SCI-Expanded, Scopus)

15. The Complementary Role of Ga-68-DOTATATE PET/CT in Neuroblastoma

TELLİ T., ERGÜN E., VOLKAN SALANCI B., Kiratli P. O.

CLINICAL NUCLEAR MEDICINE , cilt.45, sa.4, ss.326-329, 2020 (SCI-Expanded, Scopus)

16. Utility of 'dual phase' cone beam computed tomography during radioembolisation in patients with hepatocellular carcinoma: what is really changing in flow dynamics before and after Y-90 delivery?

GÖRMEZ A., ELDEM F. G., VOLKAN SALANCI B., BOZKURT M. F., UĞUR Ö., PEYNİRCİOĞLU B.

POLISH JOURNAL OF RADIOLOGY , cilt.85, 2020 (ESCI, Scopus)

17. Intertechnique Agreement in Epilepsy Imaging

GÜNEŞ A., YALNIZOĞLU D., GÜNBEY C., VOLKAN SALANCI B., SÖYLEMEZOĞLU A. F., BİLGİNER B., et al.

Türkiye Çocuk Hastalıkları Dergisi , cilt.13, sa.4, ss.292-301, 2019 (TRDizin)

18. Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience

TÜRK G., Eldem G., KILIÇKAP S., Bozkurt F. M., VOLKAN SALANCI B., ÇİL B. E., et al.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.50, sa.2, ss.236-243, 2019 (ESCI, Scopus) Sürdürülebilir Kalkınma

19. Santral Sinir Sistemi Tümörlerinde Nükleer Tıp-Nuclear Medicine in Central Nervous System Tumors

ERGÜN E., VOLKAN SALANCI B., ERBAŞ H. B.

Türkiye Klinikleri J Nucl Med , cilt.3, sa.2, ss.142-152, 2017 (Hakemsiz Dergi)

20. Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors : A-7-year Experience of a Single Institution.

Bozkurt F., VOLKAN SALANCI B., PEYNİRCİOĞLU B., Eldem G., Cil B., UĞUR Ö.

JOURNAL OF NUCLEAR MEDICINE , cilt.57, 2016 (SCI-Expanded, Scopus)

21. Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients

VOLKAN SALANCI B., Kiratli P. O.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.24, sa.2, ss.47-59, 2015 (ESCI, TRDizin)

22. Etiological yield of SNP microarrays in idiopathic intellectual disability

Ütine G. E., Halıloglu G., Volkan-Salancı B., Cetinkaya A., Kıper P. O., Alanay Y., et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , cilt.18, sa.3, ss.327-337, 2014 (SCI-Expanded, Scopus)

23. Neurochemical Evaluation of Brain Function With H-1 Magnetic Resonance Spectroscopy in Patients With Fragile X Syndrome

ÜTİNE G. E., Akpinar B., ARSLAN U. E., Kiper P. O. S., Volkan-Salanci B., Alanay Y., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , cilt.164, sa.1, ss.99-105, 2014 (SCI-Expanded, Scopus)

24. PARENTAL FACTORS IN PRENATAL DECISION MAKING AND THE IMPACT OF PRENATAL GENETIC COUNSELING: A STUDY ON TURKISH FAMILIES

Simsek-Kiper P. O., ÜTİNE G. E., Volkan-Salanci B., Alanay Y., Aktas D., ALİKAŞİFOĞLU M., et al.

GENETIC COUNSELING , cilt.25, sa.1, ss.53-62, 2014 (SCI-Expanded, Scopus)

25. The Relation Between Perfusion Pattern of Hepatic Artery Perfusion Scintigraphy and Response to Y-90 Microsphere Therapy

VOLKAN SALANCI B., BOZKURT M. F., PEYNİRCİOĞLU B., Cil B., UĞUR Ö.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.22, sa.3, ss.98-102, 2013 (ESCI, TRDizin)

26. A Homozygous Deletion in GRID2 Causes a Human Phenotype With Cerebellar Ataxia and Atrophy

Ütine G. E., Haliloglu G., Volkan Salancı B., Çetinkaya A., Şimşek Kiper P. Ö., Alanay Y., et al.

JOURNAL OF CHILD NEUROLOGY , cilt.28, sa.7, ss.926-932, 2013 (SCI-Expanded, Scopus)

27. Thyroid Cancer in Pediatric Age Group: An Institutional Experience and Review of the Literature

KIRATLI P. O., VOLKAN-SALANCI B., GUNAY E. C., Varan A., Akyuz C., Buyukpamukcu M.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.35, sa.2, ss.93-97, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Experience with Nuclear Medicine Information System

VOLKAN SALANCI B., Sahin F., Babekoglu V., UĞUR Ö.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.21, sa.3, ss.97-102, 2012 (ESCI, TRDizin)

29. The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms

VOLKAN-SALANCI B., AKSOY H., Kiratli P. O., TULUMEN E., GULER N., OKSUZOGLU B., et al.

JOURNAL OF CHEMOTHERAPY , cilt.24, sa.5, ss.285-291, 2012 (SCI-Expanded, Scopus)

30. The role of brain perfusion SPECT in moyamoya disease

Volkan-Salanci B., Ergun E., Sel C. G., Yalnizoglu D., Turanli G.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.31, sa.4, ss.216-218, 2012 (SCI-Expanded, Scopus)

31. Accelerated progression of metastatic disease shortly after Y90-microsphere treatment: Is there a causative relation?

Bozkurt M., VOLKAN SALANCI B., PEYNİRCİOĞLU B., Cil B., UĞUR Ö.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

32. Relationship of PON2 gene Ser311Cys polymorphism and serum paraoxonase activity with coronary artery disease in Turkish population

Bayrak T., Bayrak A., VOLKAN SALANCI B., Deniz A., TOKGÖZOĞLU S. L., YAVUZ B., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.37, sa.2, ss.150-155, 2012 (SCI-Expanded, Scopus, TRDizin)

33. Serum PON-1 Activity but not Q192R Polymorphism is Related to the Extent of Atherosclerosis

Bayrak A., Bayrak T., TOKGÖZOĞLU S. L., VOLKAN SALANCI B., Deniz A., YAVUZ B., et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.19, sa.4, ss.376-384, 2012 (SCI-Expanded, Scopus)

34. Can perfusion pattern in pre-therapy hepatic artery perfusion scintigraphy predict radiomicrosphere therapy response?

Volkan-Salanci B., Bozkurt M. F., Cil B., Peynircioglu B., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

35. Cerebral blood flow and cognitive function in obstructive sleep apnea syndrome

Kiratli P. O., DEMİR A. U., VOLKAN SALANCI B., DEMİR B., Sahin A.

HELLENIC JOURNAL OF NUCLEAR MEDICINE , cilt.13, sa.2, ss.138-143, 2010 (SCI-Expanded, Scopus)

36. THE RELATION BETWEEN FUNCTIONAL CARDIAC PARAMETERS AND SINGLE NUCLEOTIDE POLMORPHISMS IN GLUTATHIONE S TRANSFERASE P1 AND CARBONYL REDUCTASE3 GENES

VOLKAN SALANCI B., Tulumen E., Aksoy H., OKUTUCU S., Kiratli P. O., Oksuzoglu B., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.140, 2010 (SCI-Expanded, Scopus)

37. Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia

ERGUN E. L., VOLKAN-SALANCI B., ERTUĞRUL A., DEMİR B., Erbas B.

HELLENIC JOURNAL OF NUCLEAR MEDICINE , cilt.13, sa.1, ss.35-39, 2010 (SCI-Expanded, Scopus)

38. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response

ERTUĞRUL A., VOLKAN-SALANCI B., BAŞAR K., OGUZ K. K., DEMİR B., ERGUN E., et al.

PSYCHIATRY RESEARCH-NEUROIMAGING , cilt.174, sa.2, ss.121-129, 2009 (SCI-Expanded, Scopus)

39. The relation between functional cardiac parameters and single nucleotide polmorphisms in glutathione S transferase P1 and Carbonyl reductase3 genes

Volkan-Salanci B., Tulumen E., Kiratli P. O., Oksuzoglu B., Guler N., Tokgozoglu L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.36, 2009 (SCI-Expanded, Scopus)

40. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus

VOLKAN-SALANCI B., DAĞDELEN S., ALİKAŞİFOĞLU M., ERBAS T., HAYRAN M., Erbas B.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.10, sa.1, ss.41-50, 2009 (SCI-Expanded, Scopus)

41. A new autosomal dominant Peters' anomaly phenotype expanding the anterior segment dysgenesis spectrum

Berker N., Alanay Y., Elgin U., Volkan-Salanci B., Simsek T., Akarsu N., et al.

ACTA OPHTHALMOLOGICA , cilt.87, sa.1, ss.52-57, 2009 (SCI-Expanded, Scopus)

42. A multidisciplinary approach to the management of individuals with fragile X syndrome

ALANAY Y., Unal F., Turanli G., Alikasifoglu M., Alehan D., Akyol U., et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH , cilt.51, ss.151-161, 2007 (SCI-Expanded, SSCI, Scopus)

43. Clozapine effect on rCBF in patients with treatment-refractory schizophrenic patients.

Ertugrul A., Ergul-Lay E., Basar K., Volkan-Salanci B., Demir B., Ulug B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.32, 2005 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ B., YALÇIN ÇAKMAKLI G., YETİM ARSAVA E., VOLKAN SALANCI B., ERGÜN E., KARLI OĞUZ H. K., et al.

2023 International Congress of Parkinson's Disease and Movement Disorders, Kopenhag, Danimarka, 27 - 31 Ağustos 2023, (Özet Bildiri)

2. Prognostic Impact of Circulating Angiogenic Factors in 90Y Microsphere Treatment

MAVİ M. E., VOLKAN SALANCI B., LAY İ., ELDEM F. G., PEYNİRCİOĞLU B., YALÇIN Ş., et al.

55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON), Jodhpur, Hindistan, 16 - 19 Kasım 2023, (Özet Bildiri)

3. Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients?

Kaya G., Volkan Salancı B., Aydın G. B., Özgen Kıratlı M. P.

Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain, Barcelona, İspanya, 15 - 19 Ekim 2022, ss.71-72, (Özet Bildiri)

4. Can FDG PET-CT Predict Chemobrain in Pediatric Lymphoma Patients.

Kaya G., Volkan Salancı B., Özgen Kıratlı M. P.

Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain, Barcelona, İspanya, 15 - 19 Ekim 2022, ss.29, (Özet Bildiri)

5. Hepatik Arter Perfüzyon Sintigrafisinde Nadir Bir Ekstrahepatik Kaçak: Diyafram Krusu Kaçağı

Soydaş Turan B., Kaya G., Volkan Salancı B., Bozkurt M. F.

34. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 27 - 31 Mart 2022, ss.101, (Tam Metin Bildiri)

6. The relation between tumor metabolic parameters on F-18 FDG PET/CT, hepatic artery perfusion scan and therapy response in cholangiocellular carcinoma treated with Y-90 microspheres

Bozkurt M., VOLKAN SALANCI B., ELDEM F. G., BOZKURT M. F., PEYNİRCİOĞLU B., ÇİL B. E., et al.

EANM congress, Viyana, Avusturya, 21 - 25 Ekim 2017, cilt.44, ss.805, (Özet Bildiri)

7. Kolanjiyokarsinom Tanısıyla Karaciğer MetastazlarınaY-90 Mikroküre Tedavisi Verilmiş Hastalarda GörüntülemeYöntemleri ile Tedavi Yanıtının Değerlendirilmesi

bozkurt m., VOLKAN SALANCI B., ELDEM F. G., BOZKURT M. F., PEYNİRCİOĞLU B., ÇİL B. E., et al.

29. ULUSAL NÜKLEER TIP KONGRESİ, Türkiye, 11 - 15 Mayıs 2017, cilt.3, ss.14, (Tam Metin Bildiri)

8. ANALYSIS of MRI and 18F FDG PET Scan IN NON TRAUMATIC NON TUMORAL TEMPORAL LOBE EPILEPSY experience from an epilepsy center

GÜNEŞ A., VOLKAN SALANCI B., TEZER FİLİK F. İ., YALNIZOĞLU D., GÖÇMEN R., SAYGI S., et al.

The 2016 European Congress of Radiology, Viyana, Avusturya, 2 - 06 Mart 2016, (Özet Bildiri)

9. ASSESSMENT OF MORPHOLOGIC AND METABOLIC NEUROIMAGING IN PRACTICE OF DEMENTIA

BULUT E. G., GÜNEŞ A., ÖZKAN E., VOLKAN SALANCI B., KARLI OĞUZ H. K.

38th European Society of Neuroradiology Diagnostic and Interventional Annual Meeting, NAPOLİ, İtalya, 17 - 20 Eylül 2015, cilt.57, ss.66-67, (Özet Bildiri)

10. The value of F-18 FDG PET/CT for the early response evaluation of the Y-90 microsphere therapy in colorectal cancer patients with liver metastasis

Volkan-Salanci B., Bozkurt F. M., Peynircioglu B., Cil B., Eldem G., Ugur O.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri) Sürdürülebilir Kalkınma

11. The relation between the change of functional cardiac parameters and single nucleotide polymorphisms in Glutathione S transferase P1 and Carbonyl reductase3 genes after doxorubicin chemotherapy

Volkan-Salanci B., Tulumen E., Kiratli P. O., Oksuzoglu B., Guler N., Tokgozoglu L., et al.

15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, cilt.7, ss.107, (Özet Bildiri)